This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Butterworth, R.J. Articles by Bath, P.M.W. Search for Related Content PubMed PubMed Citation Articles by Butterworth, R.J. Articles by Bath, P.M.W.

(Stroke. 1996;27:2064-2068.)
© 1996 American Heart Association, Inc.

Articles

Serum Neuron-Specific Enolase, Carnosinase, and Their Ratio in Acute Stroke

An Enzymatic Test for Predicting Outcome?

R.J. Butterworth, MRCP; W.S. Wassif, MBChB; R.A. Sherwood, DPhil; A. Gerges, BSc; K.H. Poyser, PhD; J. Garthwaite, PhD; T.J. Peters, DSc P.M.W. Bath, MRCP

the Stroke Research Group (Department of Medicine) (R.J.B., P.M.W.B.) and Department of Clinical Biochemistry (W.S.W., R.A.S., A.G., K.H.P., T.J.P.), King's College School of Medicine and Dentistry, London, and The Wellcome Research Laboratories (J.G.), London, UK.

Correspondence to Dr P.M.W. Bath, Department of Medicine, King's College School of Medicine and Dentistry, Bessemer Rd, London SE5 9PJ, UK. E-mail p.bath@kcl.ac.uk.

Background and Purpose Few admission variables adequately predict neuronal damage and prognosis in individual patients after stroke. Therefore, there is a need for a reliable noninvasive surrogate measure of clinical outcome.

Methods We have developed a surrogate measure of stroke outcome using the ratio of serum neuron-specific enolase (NSE) to human serum carnosinase (HSC) in 124 patients with acute ischemic or hemorrhagic stroke and 61 matched control subjects. Serum NSE is known to rise and HSC to fall after neuronal injury such as cerebral ischemia.

Results Serum NSE levels were significantly higher and HSC levels lower in the patient group. The NSE/HSC ratio was elevated in patients with stroke: median (semiquartile) hemorrhages, 0.072 (0.033); infarcts, 0.039 (0.026); and control subjects, 0.019 (0.014), P=.0001. Patients with a primary intracerebral hemorrhage had nonsignificantly higher ratios than those with an infarct (P=.082). The NSE/HSC ratio was significantly associated with 90-day outcome measured in two out of three disability and handicap scales: modified Barthel Index (r_s=-.34, P=.001), modified Rankin Scale (r_s=.30, P=.002), and Lindley Score (r_s=.19, P=.057). Patients who died or were institutionalized had higher ratios than those who were discharged home: 0.069 (0.043) versus 0.038 (0.024), P=.011. Correlations between the NSE/HSC ratio and outcome were comparable to those between patient age or consciousness level on admission and clinical outcome.

Conclusions We believe that measurement of NSE, HSC, or their ratio may be useful in the assessment of patients with acute stroke with respect to diagnosis and prediction of clinical outcome.

Key Words: stroke, acute • GABA • neuron-specific enolase • serum carnosinase • stroke outcome

This article has been cited by other articles:

				N. R Grubb, C. Simpson, R. A Sherwood, H. D Abraha, S. M Cobbe, R. E O'Carroll, I. Deary, and K. A A Fox Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100 Heart, October 1, 2007; 93(10): 1268 - 1273. [Abstract] [Full Text] [PDF]

				P. Schoen, H. Everts, T. de Boer, and W. van Oeveren Serum Carnosinase Activity in Plasma and Serum: Validation of a Method and Values in Cardiopulmonary Bypass Surgery Clin. Chem., November 1, 2003; 49(11): 1930 - 1932. [Full Text] [PDF]

				S.-H. Oh, J.-G. Lee, S.-J. Na, J.-H. Park, Y.-C. Choi, and W.-J. Kim Prediction of Early Clinical Severity and Extent of Neuronal Damage in Anterior-Circulation Infarction Using the Initial Serum Neuron-Specific Enolase Level Arch Neurol, January 1, 2003; 60(1): 37 - 41. [Abstract] [Full Text] [PDF]

				M. T. Wunderlich, A. D. Ebert, T. Kratz, M. Goertler, S. Jost, and M. Herrmann Early Neurobehavioral Outcome After Stroke Is Related to Release of Neurobiochemical Markers of Brain Damage Stroke, June 1, 1999; 30(6): 1190 - 1195. [Abstract] [Full Text] [PDF]

				R. J. Butterworth, R. A. Sherwood, P. M. W. Bath, U. Missler, and M. Wismann Serum S-100 Protein in Acute Stroke • Response Stroke, March 1, 1998; 29(3): 730 - 730. [Full Text] [PDF]

				U. Missler, M. Wiesmann, C. Friedrich, and M. Kaps S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic Stroke Stroke, October 1, 1997; 28(10): 1956 - 1960. [Abstract] [Full Text]

				K. J. Becker, R. M. McCarron, C. Ruetzler, O. Laban, E. Sternberg, K. C. Flanders, and J. M. Hallenbeck Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia PNAS, September 30, 1997; 94(20): 10873 - 10878. [Abstract] [Full Text] [PDF]